Influence of IDH on FLT3-ITD status in newly diagnosed AML.

Autor:	Boddu P; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Benton CB; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Pierce S; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Cortes J; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.
Jazyk:	angličtina
Zdroj:	Leukemia [Leukemia] 2017 Nov; Vol. 31 (11), pp. 2526-2529. Date of Electronic Publication: 2017 Jul 28.
DOI:	10.1038/leu.2017.244
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink